AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn
14th Mar 2024 07:16
(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.
Read moreAstraZeneca's chemo replacement treatment moves closer to EU approval
4th Mar 2024 07:18
(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.
Read moreAstraZeneca's blood-disorder drug recommended for EU approval
26th Feb 2024 07:22
(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.
Read moreAstraZeneca acquires US-based biopharmaceutical company
20th Feb 2024 10:29
(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.
Read moreLondon close: Stocks manage gains on globally quiet day
19th Feb 2024 15:59
(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.
Read moreAstraZeneca's Tagrisso gains FDA approval
19th Feb 2024 08:03
(Sharecast News) - Drugmaker AstraZeneca traded higher early on Monday after revealing that a combination of its cancer drug Tagrisso with chemotherapy had gained US approval to treat a particular type of lung cancer.
Read moreBarclays sees "compelling" entry point at AstraZeneca after recent falls
12th Feb 2024 09:12
(Sharecast News) - Barclays has kept an 'overweight' position on AstraZeneca despite the biopharma group's disappointing annual results last week, saying that the stock's recent underperformance provides an attractive entry point for investors.
Read moreLondon close: Stocks slip as US jobless claims fall
8th Feb 2024 14:42
(Sharecast News) - London markets experienced a downturn in trading on Thursday, with stocks relinquishing earlier gains as investors processed a decrease in jobless claims in the United States.
Read moreAstraZeneca shares slip as Q4 profits miss forecasts
8th Feb 2024 07:58
(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.
Read moreLondon close: Stocks finish lower as wage growth eases
16th Jan 2024 16:17
(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.
Read moreUBS downgrades AstraZeneca to 'sell'
16th Jan 2024 08:15
(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.
Read moreLondon close: Stocks fall amid rising geopolitical concerns
3rd Jan 2024 17:48
(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.
Read moreJefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'
3rd Jan 2024 11:07
(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.
Read moreLondon close: Stocks maintain gains amid post-Christmas rally
27th Dec 2023 14:25
(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.
Read moreLondon midday: Stocks ride global wave of post-Christmas optimism
27th Dec 2023 11:20
(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.
Read more